This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.08% per year. These returns cover a period from January 1, 1988 through May 6, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Here's Why You Should Stay Away From HCA Healthcare Now
by Zacks Equity Research
HCA Healthcare (HCA) business is persistently hurt by the adverse coronavirus impact, which makes it an unattractive bet.
Acadia Healthcare Offers Senior Unsecured Notes for $475M
by Zacks Equity Research
Acadia Healthcare (ACHC) exhibits sharp business acumen by issuing senior notes to procure funds.
Zacks Industry Outlook Highlights: CYH, HCA, UHS and THC
by Zacks Equity Research
Zacks Industry Outlook Highlights: CYH, HCA, UHS and THC
UHS or THC: Which is a Better-Positioned Stock Right Now?
by Zacks Equity Research
Universal Health (UHS) and Tenet Healthcare (THC) are poised to grow. On comparative evaluation, we try to discover which is a more profitable bet based on the fundamentals.
Why Should You Add Universal Health (UHS) to Your Portfolio?
by Zacks Equity Research
Riding high on segmental contributions and a solid balance sheet, Universal Health (UHS) has potential to reap benefits for investors.
What Makes Select Medical (SEM) an Attractive Investment Pick
by Zacks Equity Research
Solid operating fundamentals and rising earnings estimate make Select Medical (SEM) a lucrative stock.
Acadia Healthcare, Covenant Health to Offer Mental Healthcare
by Zacks Equity Research
Acadia Healthcare (ACHC) and Covenant Health to unveil East Tennessee Behavioral Health to cater to the mental care services of communities in and around Knoxville.
Zacks.com featured highlights include: BXC, DBD, ARCB, CYH and CLW
by Zacks Equity Research
Zacks.com featured highlights include: BXC, DBD, ARCB, CYH and CLW
Why Should You Retain HCA Healthcare in Your Portfolio?
by Zacks Equity Research
Gaining traction from strategic moves and a solid uptake of telehealth medicines, HCA Healthcare (HCA) holds prospects of reaping benefits for investors.
5 Stocks That Brokers Favor Amid Coronavirus Crisis
by Maharathi Basu
In view of their thorough knowledge of the investing world, advice from brokers is necessary to design a winning portfolio of stocks in these coronavirus-ravaged times.
Why Is Community Health Systems (CYH) Up 15.3% Since Last Earnings Report?
by Zacks Equity Research
Community Health Systems (CYH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Community Health Up 118.9% in a Year: Further Upside Left?
by Zacks Equity Research
Community Health's (CYH) strategic measures are likely to fetch revenues, which in turn, may bump up its share price.
Community Health (CYH) Q2 Earnings Beat, Revenues Down Y/Y
by Zacks Equity Research
Community Health's (CYH) second-quarter results reflect lower costs, partially offset by softer revenues owing to decline in admissions.
Community Health Systems (CYH) Tops Q2 Earnings Estimates
by Zacks Equity Research
Community Health Systems (CYH) delivered earnings and revenue surprises of 169.67% and -0.27%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
Teladoc (TDOC) Q2 Earnings to Gain From Coronavirus-Led Demand
by Zacks Equity Research
Teladoc Health (TDOC) Q2 earnings are likely to have gained from higher virtual health visits and membership growth from coronavirus-led demand.
Community Health Systems (CYH) Expected to Beat Earnings Estimates: Should You Buy?
by Zacks Equity Research
Community Health Systems (CYH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
What's in Store for HCA Healthcare's (HCA) Q2 Earnings?
by Zacks Equity Research
HCA Healthcare's (HCA) second-quarter results are likely to reflect dented revenues due to the pandemic woes.
Acadia Healthcare Opens Mental Health Unit With Tower Health
by Zacks Equity Research
Acadia Healthcare (ACHC) unveils a facility to fortify its foothold in the mental health and behavioral healthcare market.
Tenet Healthcare Plunges 55.7% YTD: Will the Stock Rebound?
by Zacks Equity Research
Even though Tenet Healthcare (THC) endures the COVID-19 impact on global economy, it holds prospects to revive its fortunes with the help of its endeavors and strong fundamentals.
Here's Why You Should Steer Clear of HCA Healthcare Now
by Zacks Equity Research
Elevated expenses and muted revenues due to coronavirus pandemic make HCA Healthcare (HCA) an unattractive bet.
Community Health to Sell Unit for Streamlining Operations
by Zacks Equity Research
Community Health (CYH) is set to sell hospital units for debt-reduction and business rejig.
Court Ruling on Price Transparency Unsettles Hospital Stocks
by Sapna Bagaria
Stocks of most hospital companies take a hit after the federal court retains the rules pertaining to pricing transparency.
Here's Why You Should Stay Away From Universal Health (UHS)
by Zacks Equity Research
Elevated expenses and weak first-quarter results make Universal Health (UHS) an unattractive bet.
Why Is Community Health Systems (CYH) Up 3.9% Since Last Earnings Report?
by Zacks Equity Research
Community Health Systems (CYH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Hospital Industry's Dull Near-Term Outllook Induced by Coronavirus
by Sapna Bagaria
Revenue loss and cost rise due to coronavirus outbreak put hospital companies in a tight spot.